SOURCE-LINKED INTELLIGENCE

DEVELOPING LIQUID BIOPSY TESTS FOR MALIGNANT EFFUSIONS USING ARTIFICIAL INTELLIGENCE-ASSISTED, MORPHOLOGY-BASED ISOLATION OF TUMOR CELLS - PROJECT SUMMARY/ABSTRACT BACKGROUND. MALIGNANT EFFUSIONS (ME) ARE FREQUENT COMPLI

USAspending · observation · Publication date unknown

DEVELOPING LIQUID BIOPSY TESTS FOR MALIGNANT EFFUSIONS USING ARTIFICIAL INTELLIGENCE-ASSISTED, MORPHOLOGY-BASED ISOLATION OF TUMOR CELLS - PROJECT SUMMARY/ABSTRACT BACKGROUND. MALIGNANT EFFUSIONS (ME) ARE FREQUENT COMPLICATIONS OF METASTATIC BREAST CANCER (MBC) ASSOCIATED WITH SEVERE SYMPTOMS AND DIRE PROGNOSIS. TREATING MES INVOLVES PALLIATION THROUGH THE SERIAL REMOVAL OF EXCESS FLUIDS, WHICH ARE THEN TYPICALLY DISCARDED. INSTEAD, THESE FLUIDS COULD BE USED AS SUBSTRATES FOR LIQUID BIOPSY (LB) TO GUIDE THE TREATMENT OF MES AND ADVANCED MBCS. PROBLEM. DRUG TARGETS AND PREDICTORS OF RESPONSE F

Read original source ↗ Open in workspace

recordType

award

region

US

value

3364040

unit

USD